CFC Status. The Company was not a “controlled foreign corporation” (“CFC”) as defined in the U.S. Internal Revenue Code of 1986, as amended, for the taxable year ended December 31, 2022 and, based on the Company’s expectations with respect to its shareholders, the Company does not expect to be classified as a CFC for the taxable year ending December 31, 2023.
Appears in 4 contracts
Samples: Sales Agreement (Starbox Group Holdings Ltd.), Sales Agreement (Brenmiller Energy Ltd.), Sales Agreement (NeuroSense Therapeutics Ltd.)
CFC Status. The Company was not a “controlled foreign corporation” (“CFC”) as defined in the U.S. Internal Revenue Code of 1986, as amended, for the taxable year ended December 31, 2022 2021 and, based on the Company’s expectations with respect to its shareholders, the Company does not expect to be classified as a CFC for the taxable year ending December 31, 20232022.
Appears in 3 contracts
Samples: Sales Agreement (Mainz Biomed N.V.), Sales Agreement (G Medical Innovations Holdings Ltd.), Fusion Fuel Green PLC
CFC Status. The Company was not a “controlled foreign corporation” (“CFC”) as defined in the U.S. Internal Revenue Code of 1986, as amended, for the taxable year ended December 31, 2022 2020 and, based on the Company’s expectations with respect to its shareholders, the Company does not expect to be classified as a CFC for the taxable year ending December 31, 20232021.
Appears in 2 contracts
Samples: Entera Bio Ltd., Entera Bio Ltd.
CFC Status. The Company was not a “"controlled foreign corporation” " (“"CFC”") as defined in the U.S. Internal Revenue Code of 1986, as amended, for the taxable year ended December 31, 2022 2019 and, based on the Company’s 's expectations with respect to its shareholders, the Company does not expect to be classified as a CFC for the taxable year ending December 31, 20232020.
Appears in 1 contract
Samples: Portage Biotech Inc.
CFC Status. The Company was not a “"controlled foreign corporation” " (“"CFC”") as defined in the U.S. Internal Revenue Code of 1986, as amended, for the taxable year ended December 31, 2022 2020 and, based on the Company’s 's expectations with respect to its shareholders, the Company does not expect to be classified as a CFC for the taxable year ending December 31, 20232021.
Appears in 1 contract
Samples: Portage Biotech Inc.
CFC Status. The Company was not a “controlled foreign corporation” (“CFC”) as defined in the U.S. Internal Revenue Code of 1986, as amended, for the taxable year ended December 31November 30, 2022 and, based on the Company’s expectations with respect to its shareholders, the Company does not expect to be classified as a CFC for the taxable year ending December 31November 30, 2023.
Appears in 1 contract
Samples: Theratechnologies Inc.
CFC Status. The Company was not a “controlled foreign corporation” (“CFC”) as defined in the U.S. Internal Revenue Code of 1986, as amended, for the most recently completed taxable year ended December 31, 2022 and, based on the Company’s expectations with respect to its shareholders, the Company does not expect to be classified as a CFC for the current taxable year ending December 31, 2023year.
Appears in 1 contract
Samples: Tiziana Life Sciences LTD
CFC Status. The Company was not a “controlled foreign corporation” (“CFC”) as defined in the U.S. Internal Revenue Code of 1986, as amended, for the taxable year ended December 31November 30, 2022 2020 and, based on the Company’s expectations with respect to its shareholders, the Company does not expect to be classified as a CFC for the taxable year ending December 31November 30, 20232021.
Appears in 1 contract
CFC Status. The Company was not a “controlled foreign corporation” (“CFC”) as defined in the U.S. Internal Revenue Code of 1986, as amended, for the taxable year ended December 31, 2022 2019 and, based on the Company’s expectations with respect to its shareholders, the Company does not expect to be classified as a CFC for the taxable year ending December 31, 20232020.
Appears in 1 contract
Samples: Sequans Communications
